Sarnoff David 4
4 · Hoth Therapeutics, Inc. · Filed Jan 8, 2024
Insider Transaction Report
Form 4
Sarnoff David
Director
Transactions
- Award
Options
[F1]2024-01-05+25,000→ 25,000 totalExercise: $1.36From: 2024-01-05Exp: 2034-01-05→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The options were issued pursuant to the Issuer's 2022 Equity Incentive Plan and vested in full upon grant.
Signature
/s/ Hayley Springer as Attorney-In-Fact for David Sarnoff|2024-01-08